b. Reports on Form 8-K

     Form 8-K dated January 12, 2004, furnished pursuant to Item 9, in connection with an investor presentation.

     Form 8-K dated January 13, 2004, furnished pursuant to Item 9, in connection with our issuance of a press release on January 12, 2004 announcing a presentation at a healthcare conference.

     Form 8-K dated February 5, 2004, furnished pursuant to Item 12, in connection with our issuance of a press release on February 4, 2004 reporting our results for the three months ended December 31, 2003.

     Form 8-K dated February 12, 2004, furnished pursuant to Item 12, in connection with the script of the earnings call held February 5, 2004.

     Form 8-K dated February 12, 2004, furnished pursuant to Item 9, in connection with our issuance of a press release on February 11, 2004 announcing the declaration of a quarterly cash dividend, and our issuance of a press release on February 11, 2004 announcing the appointment of Thomas Scully to the Board of Directors.

     Form 8-K dated February 17, 2004, furnished pursuant to Item 9, in connection with an investor presentation.

     Form 8-K dated February 24, 2004, furnished pursuant to Item 9, in connection with our issuance of a press release on February 23, 2004 announcing the authorization of a stock repurchase program.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SELECT MEDICAL CORPORATION
	By:	/s/      Martin F. Jackson
		Martin F. Jackson
		Senior Vice President and Chief Financial Officer (Duly Authorized Officer)

	By:	/s/     Scott A. Romberger
		Scott A. Romberger
		Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)

Dated: May 10, 2004

- 31 -